TBIO Dividend: Telesis Bio Inc Yield Insights

Income

Balance sheet

Cash flow

Annual

Quarterly

TBIO Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019
Revenue	13	27	27	11	6	4
Revenue Growth (YoY)	-56.99%	0%	145%	83%	50%	--
Cost of Revenue	7	10	11	6	2	2
Gross Profit	6	16	15	4	3	2
Selling, General & Admin	25	34	38	25	11	5
Research & Development	11	17	23	14	8	3
Operating Expenses	36	52	62	39	19	9
Other Non Operating Income (Expenses)	0	0	0	0	0	0
Pretax Income	-44	-47	-48	-38	-18	-8
Income Tax Expense	0	0	0	0	0	0
Net Income	-47	-49	-48	-38	-18	-8
Net Income Growth	24%	2%	26%	111%	125%	--
Shares Outstanding (Diluted)	1.77	1.65	1.63	1.01	1.62	1.62
Shares Change (YoY)	7%	1%	62%	-38%	0%	--
EPS (Diluted)	-27.03	-29.56	-29.61	-38.48	-11.09	-5.11
EPS Growth	16%	0%	-23%	247%	117%	--
Free Cash Flow	-23	-36	-43	-38	-15	-6
Free Cash Flow Per Share	-12.97	-21.71	-26.26	-37.54	-9.23	-3.69
Gross Margin	46.15%	59.25%	55.55%	36.36%	50%	50%
Operating Margin	-230.76%	-129.62%	-170.37%	-318.18%	-266.66%	-150%
Profit Margin	-361.53%	-181.48%	-177.77%	-345.45%	-300%	-200%
Free Cash Flow Margin	-176.92%	-133.33%	-159.25%	-345.45%	-250%	-150%
EBITDA	-28	-33	-45	-35	-16	-6
EBITDA Margin	-215.38%	-122.22%	-166.66%	-318.18%	-266.66%	-150%
D&A For EBITDA	2	2	1	0	0	0
EBIT	-30	-35	-46	-35	-16	-6
EBIT Margin	-230.76%	-129.62%	-170.37%	-318.18%	-266.66%	-150%
Effective Tax Rate	0%	0%	0%	0%	0%	0%